7/12/22, 6:09 PM
`
`Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone
`
`ABOUT AGILENT CONTACT US UNITED STATES
`
`ACCOUNT
`
`PRODUCTS
`
`APPLICATIONS & INDUSTRIES
`
`TRAINING & EVENTS
`
`SERVICES
`
`SUPPORT & RESOURCES
`
`ORDER CENTER
`
`Home > About > Newsroom > Press Releases > Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone
`
`All
`
`SEARCH
`
`0
`
`|
`
`Newsroom
`
`Newsroom Navigation
`
`Media Contact
`
`Naomi Goumillout
`Agilent Technologies Inc
`+1 978 314 1862
`naomi.goumillout@agilent.com
`
`Photos
`
`Carl H. June JPG ( 1.0 MB)
`
`Michael Milone JPG ( 400.0 KB)
`
`Press Release
`
`Agilent Presents
`Thought Leader Award
`to Drs. Carl H. June
`and Michael Milone
`University of Pennsylvania
`scientists recognized for their
`contributions to the field of CAR
`T-cell mediated cancer
`immunotherapy
`SANTA CLARA, Calif., November 17, 2020
`
`Agilent Technologies Inc. (NYSE:
`A) today announced professors
`Carl H. June, MD, and Michael
`Milone, MD, Ph.D., as recipients of
`an Agilent Thought Leader Award.
`Both scientists are being
`recognized for their joint
`contributions to the field of CAR
`T-cell mediated cancer
`immunotherapy, having
`codeveloped tisagenlecleucel
`(Kymriah™), the first cell and gene
`therapy product approved by the
`US FDA.
`
`The award will focus on defining
`standards for the design,
`validation, and manufacturing of
`cell-based cancer therapeutics.
`Combining metabolomic and cell-
`based tools with more efficient
`CRISPR-based engineering of T-
`cells will allow labs to validate
`and maintain quality control
`
`https://www.agilent.com/about/newsroom/presrel/2020/17nov-ca20030.html
`
`1/4
`
`UPenn Ex. 2025
`Miltenyi v. UPenn
`IPR2022-00855
`
`
`
`Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone
`
`ABOUT AGILENT CONTACT US UNITED STATES
`
`ACCOUNT
`
`PRODUCTS
`
`APPLICATIONS & INDUSTRIES
`
`TRAINING & EVENTS
`
`SERVICES
`
`SUPPORT & RESOURCES
`
`ORDER CENTER
`
`Home > About > Newsroom > Press Releases > Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone
`
`All
`
`SEARCH
`
`0
`
`|
`
`Newsroom
`
`Newsroom Navigation
`
`Media Contact
`
`Naomi Goumillout
`Agilent Technologies Inc
`+1 978 314 1862
`naomi.goumillout@agilent.com
`
`Photos
`
`Carl H. June JPG ( 1.0 MB)
`
`Michael Milone JPG ( 400.0 KB)
`
`Press Release
`
`Agilent Presents
`Thought Leader Award
`to Drs. Carl H. June
`and Michael Milone
`University of Pennsylvania
`scientists recognized for their
`contributions to the field of CAR
`T-cell mediated cancer
`immunotherapy
`SANTA CLARA, Calif., November 17, 2020
`
`Agilent Technologies Inc. (NYSE:
`A) today announced professors
`Carl H. June, MD, and Michael
`Milone, MD, Ph.D., as recipients of
`an Agilent Thought Leader Award.
`Both scientists are being
`recognized for their joint
`contributions to the field of CAR
`T-cell mediated cancer
`immunotherapy, having
`codeveloped tisagenlecleucel
`(Kymriah™), the first cell and gene
`therapy product approved by the
`US FDA.
`
`The award will focus on defining
`standards for the design,
`validation, and manufacturing of
`cell-based cancer therapeutics.
`Combining metabolomic and cell-
`based tools with more efficient
`CRISPR-based engineering of T-
`cells will allow labs to validate
`and maintain quality control
`
`https://www.agilent.com/about/newsroom/presrel/2020/17nov-ca20030.html
`
`1/4
`
`UPenn Ex. 2025
`Miltenyi v. UPenn
`IPR2022-00855
`
`
`
`7/12/22, 6:09 PM
`
`Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone
`downstream in development and
`manufacturing.
`
`Agilent will provide modified
`gRNAs and oligonucleotide
`libraries to optimize the
`engineering of patient T-cells.
`Agilent will also provide
`instruments including an
`xCELLigence RTCA eSight, a
`NovoCyte Quanteon Flow
`Cytometer, a 6546 LC/Q-TOF
`Mass Spectrometer, and a 2100
`Bioanalyzer system, which will
`work in concert with cell
`engineering advances to enable
`the development of protocols and
`workflows for characterization
`and selection of the best
`approaches to T-cell engineering.
`
`“It’s an honor to be chosen for an
`Agilent Thought Leader Award.
`Partnering with Agilent will help
`strengthen our research in areas
`with a critical impact on cancer
`treatment,” said Dr. June.
`
`“Receiving this Agilent award will
`enable us to improve the
`generation and characterization
`of cell-based products and
`therapeutics,” added Dr. Milone.
`
`“The Thought Leader Award
`program is about promoting
`fundamental scientific
`advancements,” said Kevin
`Meldrum, vice president and
`general manager of Agilent’s
`Genomics Division, and executive
`sponsor of the award. “The work
`of Drs. June and Milone embody
`what Agilent aims to celebrate
`and advance.”
`
`Dr. June is the Richard W. Vague
`Professor of Immunotherapy,
`director of the Center for Cellular
`Immunotherapies, and director of
`the Parker Institute for Cancer
`Immunotherapy at the Perelman
`School of Medicine of the
`University of Pennsylvania. He is
`a graduate of the Naval Academy
`in Annapolis and Baylor College
`of Medicine in Houston, 1979. Dr.
`Milone is an associate professor
`of Pathology and Laboratory
`Medicine and founding member
`of the Center for Cellular
`Immunotherapies at the
`
`https://www.agilent.com/about/newsroom/presrel/2020/17nov-ca20030.html
`
`2/4
`
`UPenn Ex. 2025
`Miltenyi v. UPenn
`IPR2022-00855
`
`
`
`7/12/22, 6:09 PM
`
`Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone
`Perelman School of Medicine. He
`is a graduate of Stevens Institute
`of Technology and earned his MD
`and Ph.D. in 1999 from the
`University of Medicine and
`Dentistry of New Jersey.
`
`The Agilent Thought Leader
`Award program promotes
`fundamental scientific advances
`by contributing financial support,
`products, and expertise to the
`research of influential thought
`leaders in the life sciences,
`diagnostics, and chemical
`analysis space. To learn more,
`visit the Agilent Thought Leader
`Award webpage.
`
`About Agilent Technologies
`
`Agilent Technologies Inc. (NYSE: A) is
`a global leader in life sciences,
`diagnostics, and applied chemical
`markets. In its 20th year as an
`independent company delivering
`insight and innovation toward
`improving the quality of life, Agilent
`instruments, software, services,
`solutions, and people provide trusted
`answers to customers' most
`challenging questions. The company
`generated revenue of $5.16 billion in
`fiscal 2019 and employs 16,300
`people worldwide. Information
`about Agilent is available
`at www.agilent.com. To receive the
`latest Agilent news, subscribe to the
`Agilent Newsroom.
`Follow Agilent on LinkedIn, Twitter,
`and Facebook.
`
`Newsroom Highlights
`
`Agilent Reports Second-Quarter
`Fiscal Year 2022 Financial
`Results
`
`Statement on Ukraine and
`Agilent Business Operations in
`Russia
`
`Analysis of PFAS i
`
`Published Editorial
`
`Agilent Press Release
`
`Company Statement
`
`https://www.agilent.com/about/newsroom/presrel/2020/17nov-ca20030.html
`
`3/4
`
`UPenn Ex. 2025
`Miltenyi v. UPenn
`IPR2022-00855
`
`
`
`7/12/22, 6:09 PM
`
`Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone
`
`
`
`ABOUT AGILENT
`
`RESOURCES
`
`SHOPPING TOOLS
`
`Newsroom
`Company Information
`Investor Relations
`Careers
`Community Relations
`Working With Agilent
`University Relations
`Sustainability
`
`Literature Library
`Video Library
`Events
`E-Seminars
`Training Courses
`E-Newsletters
`Android Mobile Apps
`IOS Mobile Apps
`
`Buy Online
`Quick Order
`My Account
`My Favorites
`My Orders
`Where To Buy
`Promotions & Offers
`
`SUPPORT &
`SERVICES
`
`Agilent Community
`Technical Support
`On-Site Services
`Analytical Instrument
`Services
`Vacuum Product
`Services
`Financial Solutions
`
`Headquarters | Other sites
`5301 Stevens Creek Blvd.
`Santa Clara, CA 95051
`United States
`
`Worldwide Emails
`
`Worldwide Numbers
`
`Privacy Statement | Terms of Use | Contact Us | Accessibility
`
`© 2022 Agilent Technologies, Inc.
`
`Privacy Statement | Terms of Use | Contact Us | Accessibility
`
`Headquarters | Other sites
`5301 Stevens Creek Blvd.
`Santa Clara, CA 95051
`United States
`
`Worldwide Emails
`
`Worldwide Numbers
`
`© 2022 Agilent Technologies, Inc.
`
`https://www.agilent.com/about/newsroom/presrel/2020/17nov-ca20030.html
`
`4/4
`
`UPenn Ex. 2025
`Miltenyi v. UPenn
`IPR2022-00855
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
